Pathetic SP Result

So why aren't we trading up +88% today...

Here's some insight from TheStreet:

TheStreet Ratings team rates UNILIFE CORP as a Sell with a ratings score of D-. TheStreet Ratings Team has this to say about their recommendation:
"We rate UNILIFE CORP (UNIS) a SELL. This is driven by multiple weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, weak operating cash flow, generally disappointing historical performance in the stock itself and generally high debt management risk."
Highlights from the analysis by TheStreet Ratings Team goes as follows:

• Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness within the corporation. Compared to other companies in the Health Care Equipment & Supplies industry and the overall market, UNILIFE CORP's return on equity significantly trails that of both the industry average and the S&P 500.
• Net operating cash flow has significantly decreased to -$23.62 million or 126.53% when compared to the same quarter last year. In addition, when comparing to the industry average, the firm's growth rate is much lower.
• The debt-to-equity ratio is very high at 9.04 and currently higher than the industry average, implying increased risk associated with the management of debt levels within the company. Regardless of the company's weak debt-to-equity ratio, UNIS has managed to keep a strong quick ratio of 1.53, which demonstrates the ability to cover short-term cash needs.
• UNIS's stock share price has done very poorly compared to where it was a year ago: Despite any rallies, the net result is that it is down by 36.97%, which is also worse that the performance of the S&P 500 Index. Investors have so far failed to pay much attention to the earnings improvements the company has managed to achieve over the last quarter. Naturally, the overall market trend is bound to be a significant factor. However, in one sense, the stock's sharp decline last year is a positive for future investors, making it cheaper (in proportion to its earnings over the past year) than most other stocks in its industry. But due to other concerns, we feel the stock is still not a good buy right now.
• The gross profit margin for UNILIFE CORP is currently very high, coming in at 100.00%. It has increased from the same quarter the previous year. Regardless of the strong results of the gross profit margin, the net profit margin of -233.16% is in-line with the industry average.

http://www.thestreet.com/story/12903584/1/why-unilife-unis-stock-is-up-today.html

So where are all the syringe Deals.
Pump agreements are very welcome, but are 2yrs+ away..!
We've been lead up the garden path for far too long.
Just a truthful long suffering Longs point of view...
nln... sure.

More DEALS AS..!
.
.